Kris Persaud

1.8k total citations
20 papers, 1.3k citations indexed

About

Kris Persaud is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kris Persaud has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kris Persaud's work include Angiogenesis and VEGF in Cancer (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lymphatic System and Diseases (7 papers). Kris Persaud is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Lymphatic System and Diseases (7 papers). Kris Persaud collaborates with scholars based in United States, Switzerland and Germany. Kris Persaud's co-authors include Bronislaw Pytowski, Yan Wu, Mihaela Skobe, Larry Witte, Daniel J. Hicklin, Bryan Kloos, Nicole Roberts, Simona Podgrabinska, Zhenping Zhu and Jeremy Goldman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Kris Persaud

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kris Persaud United States	15	800	771	352	182	141	20	1.3k
M. S. Berger United States	19	948 1.2×	857 1.1×	373 1.1×	210 1.2×	26 0.2×	37	2.1k
Quteba Ebrahem United States	18	222 0.3×	808 1.0×	252 0.7×	79 0.4×	52 0.4×	31	1.5k
Kyoko Arai Japan	18	250 0.3×	595 0.8×	113 0.3×	93 0.5×	55 0.4×	53	1.0k
Michael Kuehl United States	18	287 0.4×	1.1k 1.4×	274 0.8×	138 0.8×	58 0.4×	46	1.8k
Denis M. Schewe Germany	18	632 0.8×	653 0.8×	101 0.3×	87 0.5×	39 0.3×	54	1.6k
Guangpei Hou Canada	18	180 0.2×	415 0.5×	132 0.4×	113 0.6×	53 0.4×	25	1.2k
Vittoria Cioce United States	10	337 0.4×	842 1.1×	81 0.2×	109 0.6×	55 0.4×	11	1.3k
Satoru Shinriki Japan	24	568 0.7×	850 1.1×	79 0.2×	146 0.8×	108 0.8×	59	1.5k
Philippe Quittet France	22	501 0.6×	416 0.5×	139 0.4×	43 0.2×	95 0.7×	49	1.6k
Ingrid Raab Austria	10	685 0.9×	391 0.5×	63 0.2×	297 1.6×	238 1.7×	10	1.2k

Countries citing papers authored by Kris Persaud

Since Specialization

Citations

This map shows the geographic impact of Kris Persaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris Persaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris Persaud more than expected).

Fields of papers citing papers by Kris Persaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kris Persaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris Persaud. The network helps show where Kris Persaud may publish in the future.

Co-authorship network of co-authors of Kris Persaud

This figure shows the co-authorship network connecting the top 25 collaborators of Kris Persaud. A scholar is included among the top collaborators of Kris Persaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kris Persaud. Kris Persaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brennan, Laura, Marie Prewett, Inga Duignan, et al.. (2014). A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth. Cancer Biology & Therapy. 15(9). 1208–1218. 11 indexed citations

Haidar, Jaafar N., Wei Zhu, Jacqueline Lypowy, et al.. (2014). Backbone Flexibility of CDR3 and Immune Recognition of Antigens. Journal of Molecular Biology. 426(7). 1583–1599. 16 indexed citations

Shen, Yang, Lin Zeng, Aiping Zhu, et al.. (2013). Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity. mAbs. 5(3). 418–431. 16 indexed citations

Kang, Yun, Julia Lee, Nripen Singh, et al.. (2013). Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes. Biotechnology and Bioengineering. 110(11). 2928–2937. 50 indexed citations

Doody, Jacqueline, Sneha Mathew, Lan Wu, et al.. (2012). Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models. Cancer Research. 72(8_Supplement). 3539–3539. 1 indexed citations

Franklin, Matthew C., Elizabeth Navarro, Yujie Wang, et al.. (2011). The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies. Structure. 19(8). 1097–1107. 44 indexed citations

Patel, Dipa, Xuemei Guo, Maxine Melchior, et al.. (2010). IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab. Human Antibodies. 19(4). 89–99. 65 indexed citations

Zhong, Zhaojing, Kyla Driscoll Carroll, Michael Gregory, et al.. (2009). Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells. Cancer Research. 69. 844–844. 1 indexed citations

Shen, Juqun, Marie Prewett, Haifan Zhang, et al.. (2009). Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody. Neoplasia. 11(6). 594–604. 50 indexed citations

10.

Laakkonen, Pirjo, Marika Waltari, Tanja Holopainen, et al.. (2007). Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth. Cancer Research. 67(2). 593–599. 184 indexed citations

11.

Cursiefen, Claus, Lu Chen, Magali Saint‐Geniez, et al.. (2006). Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proceedings of the National Academy of Sciences. 103(30). 11405–11410. 219 indexed citations

12.

Roberts, Nicole, Bryan Kloos, Simona Podgrabinska, et al.. (2006). Inhibition of VEGFR-3 Activation with the Antagonistic Antibody More Potently Suppresses Lymph Node and Distant Metastases than Inactivation of VEGFR-2. Cancer Research. 66(5). 2650–2657. 238 indexed citations

13.

Pytowski, Bronislaw, Jeremy Goldman, Kris Persaud, et al.. (2005). Complete and Specific Inhibition of Adult Lymphatic Regeneration by a Novel VEGFR-3 Neutralizing Antibody. JNCI Journal of the National Cancer Institute. 97(1). 14–21. 201 indexed citations

14.

Wang, Jianfeng, Bala Chandran, Kris Persaud, et al.. (2005). Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection. Journal of Biological Chemistry. 280(28). 26216–26224. 32 indexed citations

15.

Jimenez, Xenia, Dan Lu, Laura Brennan, et al.. (2005). A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3. Molecular Cancer Therapeutics. 4(3). 427–434. 47 indexed citations

16.

Persaud, Kris, Jeremy Goldman, Marie Prewett, et al.. (2004). 162 In vivo effects of a monoclonal antibody to the murine VEGFR-3 that antagonizes the binding of VEGF-C and receptor signaling. European Journal of Cancer Supplements. 2(8). 51–51. 1 indexed citations

17.

Persaud, Kris, Jean‐Christophe Tille, Meilin Liu, et al.. (2004). Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C. Journal of Cell Science. 117(13). 2745–2756. 63 indexed citations

18.

Lü, Dan, Paul Kussie, Bronislaw Pytowski, et al.. (2000). Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies. Journal of Biological Chemistry. 275(19). 14321–14330. 59 indexed citations

19.

Lü, Dan, Helen Kotanides, Xenia Jimenez, et al.. (1999). Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. Journal of Immunological Methods. 230(1-2). 159–171. 29 indexed citations

20.

Hsia, Carleton J. C., et al.. (1986). ATP—hemoglobin purification by ATP—agarose affinity chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 381(1). 153–157. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact